1 / 7

Millions of people have a drug problem ! They can not get any !

Millions of people have a drug problem ! They can not get any !. Lack of Effective , Affordable and Easy-to-use Medicines, Vaccines & Diagnostic tools. Increasing resistance to older medicines Discontinued production of effective medicines Existing –new- drugs are too expensive

shaun
Download Presentation

Millions of people have a drug problem ! They can not get any !

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Millions of people have a drug problem !They can not get any !

  2. Lack of Effective, Affordable and Easy-to-use Medicines, Vaccines & Diagnostic tools • Increasing resistance to older medicines • Discontinued production of effective medicines • Existing –new- drugs aretoo expensive • Very few new drugs are developed to tackle major diseases affecting the poorest countries (despite significant scientific/technological advances) >>> lack of R&D

  3. Tropical diseases: 13 Tuberculosis: 3 Drug Development Outcome 1975-1999:1393 new chemical entities marketed Halofantrine, Mefloquine, Artemeter, Atovaquone, Benznidazole, Nifurtimox, Albendazole, Eflornithine, Ivermectine, Oxamniquine, Praziquantel, Pentamidine isetionate, Liposomal Amphoterizin B. Trouiller et al., Lancet 2002, 359:2188-94

  4. GAP GAP GAP The R&D Process Scientific literature (patent applications) Pharmaceutical Industry 2-5 years 3-10 years Pre-clinical research Basic research Clinical research Post- Marketing Cumulative efforts scientific community. Includes discovery research leading to the identification of targets and lead-compounds Screening and optimization Synthesis, extraction Dosage & stability Toxicology-safety Phase I-II-III clinical studies Bioavailability Upscaling production Regulatory review Patients Public sector

  5. R&D is needed to ensure that new essential medicines, vaccines and diagnostics are developed and become available to people in developing countries. • New effective drugs & diagnostic tests for • Malaria • Sleeping sickness & Chagas disease • Viceral leishmaniasis • TB • Monitoring tools (VL & CD4) for HIV-patients on HAART • Preventive/therapeutic vaccine against HIV-virus High priority needs

  6. DNDi’s Founding Partners are: 1. Médecins Sans Frontières (MSF)2. Oswaldo Cruz Foundation/Fiocruz (Brazil)3. Indian Council of Medical Research (India)4. Institut Pasteur (France) 5. Ministry of Health (Malaysia) 6. Kenya Medical Research Institute (Kenya) Objective is to develop and make available drugs for neglected diseases on a not-for-profit basis. It will achieve this by building a needs-driven portfolio of short, medium, and long-term R&D projects, raising awareness about the issue, and strengthening R&D capacity via the implementation of projects in countries where these diseases are endemic.

  7. Changing Global Rules • Ensuring access to essential medicines = public responsibility • Define a needs-driven international R&D priority agenda • Outline an agreement and clear rationale for sharing the burden of the cost of this R&D • Commit all countries to contribute to R&D for health • Establish and strengthen international mechanisms for exchanging and transferring research results, knowledge, and technology • Deal with regulatory barriers to drug/vaccine development • Ensure that developing country involvement in R&D is central, including through north-south and south-south collaboration, and through the conduct of such R&D in disease-endemic countries

More Related